scholarly article | Q13442814 |
P356 | DOI | 10.1191/0961203305LU2249OA |
P698 | PubMed publication ID | 16425574 |
P2093 | author name string | S Tang | |
F K Li | |||
K N Lai | |||
T M Chan | |||
C S-O Tang | |||
K C Tse | |||
P2860 | cites work | Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes | Q28188162 |
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy | Q29615215 | ||
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus | Q33974679 | ||
Prognostic factors in lupus nephritis. Contribution of renal histologic data | Q36600287 | ||
Albumin stimulates interleukin-8 expression in proximal tubular epithelial cells in vitro and in vivo | Q39741161 | ||
Anaemia in dialysis patients as a side-effect of sartanes | Q42540628 | ||
Add-on angiotensin receptor blockade with maximized ACE inhibition | Q43623110 | ||
Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide | Q43993205 | ||
Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial | Q44280775 | ||
Long-term study of mycophenolate mofetil as continuous induction and maintenance treatment for diffuse proliferative lupus nephritis | Q44826001 | ||
Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy | Q45247211 | ||
Long-term outcome of patients with diffuse proliferative lupus nephritis treated with prednisolone and oral cyclophosphamide followed by azathioprine. | Q46467090 | ||
Antiproteinuric effect of ARB in lupus nephritis patients with persistent proteinuria despite immunosuppressive therapy. | Q46467093 | ||
Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy | Q57704237 | ||
P433 | issue | 12 | |
P921 | main subject | lupus nephritis | Q1621830 |
P304 | page(s) | 947-952 | |
P577 | publication date | 2005-01-01 | |
P1433 | published in | Lupus | Q6704846 |
P1476 | title | Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria | |
P478 | volume | 14 |
Q34044918 | Angiotensin-converting enzyme inhibitors delay the occurrence of renal involvement and are associated with a decreased risk of disease activity in patients with systemic lupus erythematosus--results from LUMINA (LIX): a multiethnic US cohort |
Q41540102 | Consensus of the Brazilian Society of Rheumatology for the diagnosis, management and treatment of lupus nephritis |
Q33882751 | Current status of lupus nephritis |
Q36302245 | Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis |
Q43626306 | New perspectives and insights to Asian systemic lupus erythematosus: renal disease, genetic predisposition and disease activity |
Q36915693 | New treatment strategies for proliferative lupus nephritis: keep children in mind! |
Q38123242 | Overview of lupus nephritis management guidelines and perspective from Asia |
Q38175076 | Overview of lupus nephritis management guidelines and perspective from Asia. |
Q37953243 | Recent advances in the treatment of lupus nephritis |
Q33806541 | Recent advances in the understanding of renal inflammation and fibrosis in lupus nephritis. |
Q38629539 | Renin-Angiotensin system inhibitors reduce serum asymmetric dimethylarginine levels and oxidative stress in normotensive patients with chronic kidney disease |
Q36712941 | Taming lupus-a new understanding of pathogenesis is leading to clinical advances |
Q37113440 | Therapy Insight: cardiovascular disease in pediatric systemic lupus erythematosus |
Q42728756 | Treatment of lupus nephritis |
Q37822658 | Treatment of proliferative lupus nephritis: a slowly changing landscape |
Q38271125 | Treatment of severe lupus nephritis: the new horizon. |
Search more.